Another antihypertensive combo approved
Azor (amlodipine/olmesartan medoxomil, Daiichi Sankyo) was recently approved by the FDA as a once-daily, oral tablet containing both a calcium channel blocker and an angiotensin receptor blocker.
Genentech to stop supplying Avastin to compounders next year
Genentech has postponed the date for stopping the sale of Avastin to compounding pharmacies from Nov. 30 to Jan. 1.
Immunization tracking system expanded
Medication Pathfinder Network has improved the tracking and reporting of immunizations for its MTM system.
New MTM program offered in North Carolina
Outcomes will administer the ChecKmeds Medicare Part D medication therapy management program in North Carolina.
Topical human thrombin helps arrest bleeding
The first human thrombin approved since 1954 will soon be available. Evithrom received approval of its Biological License Application by the FDA.
New Products October 22, 2007
Branded pharmaceuticals, generics, OTCs, home-health products, health and beauty items
The new dynamic duo
Is a new effort to codevelop drugs and diagnostics just an interesting concept or the future of drug development?
Ten Tips for MTM success
Pharmacists share tips for successful medication therapy management programs.
Outcomes upgrades MTM system
Outcomes Pharmaceutical Health Care has released a new version of its medication therapy management (MTM) systems.
Manufacturer cuts off compounding pharmacies' access to its drug
The eye care community is disconcerted by Genentech's decision to restrict access to its cancer drug Avastin.
MMWR reports on colchicine deaths due to compounding error
Three deaths determined to be result of colchicine toxicity
Medi-Promotions expands Medi-Scripts prescription pad model
Medi-Promotions to launch Medi-Scripts Plus prescription pad
Biogenerics to be reimbursed within six months on the market
U.S. payers to incorporate biogeneric agents into their formularies
Anticholesterol drug gains new name
Mipomersen sodium is the new generic name for Isis Pharmaceuticals' anticholesterol drug ISIS 301012.
N.J. e-prescribing pilot from Aetna shows increase in use of generics
Aetna's New Jersey e-prescribing pilot shows increase in generics
FDA launches GIVE to streamline generic drug approval process
FDA launches initiative to bolster generic drug program
Latebreakers: FDA bill draws widespread approval
Pharmacy and consumer groups approve of new FDA bill that will track drug safety after approval and speed some generic drugs to market.
FDA says it's not against compounding
The Food and Drug Administration most emphatically is not against compounding of drugs, Steven Silverman, a key enforcement officer in that agency, told the National Association of Boards of Pharmacy recently.
Vitamins for vision: The eyes have it
This article reveals new vitamins and dietary supplements that promote eye health.
Survey results highlight need for addiction education
Medical board survey shows increased prosecution of overprescribers and need for addiction education
Senate and House consider AMP fixes
The Fair Medicaid Drug Payment Act of 2007 would fix the average manufacturers price rule and promote generic drugs.
New MTM plan in the works for Maryland and D.C.
QIO sets up new MTM program for Maryland and District of Columbia
Wal-Mart expands $4 generic program
Wal-Mart expands its $4 generic plan to include more generics and adds birth control Rxs for $9.
Viewpoint: Bigfoot, Loch Ness monster, medication therapy management
Most pharmacists are still not providing medication therapy management, although it is required by law under Medicare Part D.
Community R.Ph.s leaving growing mark in MTM programs
New medication therapy management programs are expanding community practice opportunities.
Late-stage HTN drugs show promise
A medication in a new class of drugs has received FDA approval for hypertension and we now have several promising and innovative agents in late-stage development for treatment of the condition.
Report shows slow progress on antimicrobial misuse
Decades of campaigns against antibiotic overuse have produced only marginal reductions in use.
Clinical Twisters: Hypertension: Upping the ante
Patient appears asymptomatic for heart failure; has hypertension and diabetes, what is the maximum dose of Losartan?
New guide adds options for kidney cancer
Recent approvals have provided new options for treating kidney cancer. Updated guidelines will help utilize the new drugs.
Multiple changes spawn new UA/NSTEMI guidelines
The American College of Cardiology and the American Heart Association have updated their guidelines for the drug therapy used to treat patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction.
